Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Trulieve Cannabis ( (TSE:TRUL) ) has shared an announcement.
Trulieve Cannabis Corp. is expanding its Florida footprint with a new medical cannabis dispensary in DeLand, located on North Woodland Boulevard, as part of its strategy to deepen its presence in key markets. The company will offer walk-in and express pickup services with extended hours, complementing its statewide home delivery, online ordering, and in-store pickup options to improve patient access.
The DeLand location will stock a broad range of Trulieve in-house brands alongside exclusive partner labels, reinforcing the company’s positioning as a one-stop shop for medical cannabis patients in Florida. Targeted discounts for veterans and first-time customers underscore Trulieve’s focus on patient acquisition and loyalty, supporting continued growth in one of its core markets.
The most recent analyst rating on (TSE:TRUL) stock is a Hold with a C$9.00 price target. To see the full list of analyst forecasts on Trulieve Cannabis stock, see the TSE:TRUL Stock Forecast page.
Spark’s Take on TSE:TRUL Stock
According to Spark, TipRanks’ AI Analyst, TSE:TRUL is a Neutral.
The score is primarily supported by strong recent cash flow and improving operating profitability, reinforced by earnings-call focus on sustained cash generation and stable gross margins. It is held back by sharp TTM revenue decline, ongoing net losses, and weak technical momentum (below key moving averages with negative MACD).
To see Spark’s full report on TSE:TRUL stock, click here.
More about Trulieve Cannabis
Trulieve Cannabis Corp. is a vertically integrated, multi-state cannabis operator with leading market positions in Arizona, Florida, and Pennsylvania. The company focuses on medical and adult-use cannabis through a hub-based retail and distribution strategy, offering a portfolio of in-house and partner brands aimed at delivering high-quality products and patient-focused experiences across the U.S. market.
Average Trading Volume: 218,964
Technical Sentiment Signal: Sell
Current Market Cap: C$1.6B
For an in-depth examination of TRUL stock, go to TipRanks’ Overview page.